Meet PSEN1: A Newly Discovered Genetic Biomarker for Alzheimer’s
Researchers have identified a gene called Presenilin1, or PSEN1, as a potential new biomarker for Alzheimer’s disease. In mice and human samples, the researchers…
Researchers have identified a gene called Presenilin1, or PSEN1, as a potential new biomarker for Alzheimer’s disease. In mice and human samples, the researchers…
This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. An Alzheimer’s diagnosis is often talked about…
Alzheimer’s disease affects one in 10 people over the age of 65 and one in three over the age of 85, and its global…
Alzheimer’s disease is often thought of as a condition that only affects the elderly. But around 3.9 million people worldwide aged 30 to 64…
This article was made possible through sponsorship by Alzheon. Being Patient’s editorial team produced the interview with no review/approval process by the sponsor. Alzheimer’s…
This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. Michele Castro’s mother and brother both passed…
On Friday, August 11th at 10:00 a.m. PT/1:00 p.m. ET, Alzheimer’s advocate Michele Castro joins Being Patient Live Talks. Castro inherited the PSEN1 genetic…
This article was made possible through sponsorship by Lexeo Therapeutics. Being Patient’s editorial team produced the interview and article with no review/approval process by the…
A 19-year-old man from China, who has been having memory problems since the age of 17, was diagnosed with dementia, according to a recent…
The hunt for the genetic causes of Alzheimer’s is underway. But there are more than 20,000 genes encoded in our DNA — and that’s…
Scientists examine the curious case of a woman with genes for early-onset Alzheimer’s who never developed the disease. In an autopsied brain, they found…
When younger people receive an Alzheimer’s diagnosis, it’s often met with confusion. Many people aren’t aware that this fatal, neurodegenerative form of dementia can…
There were more than 140 experimental Alzheimer’s drugs in clinical trials as of the start of 2022. On the one hand, this number inspires…
Breakthrough advancements in gene-sequencing technologies have opened up new pathways for understanding health and disease. Scientists can sequence our genetic code to search for…
A new approach to genome sequencing newly identifies 13 rare gene variants potentially associated with Alzheimer’s. Dr. Rudy Tanzi, vice chair of neurology and…